[1] 吴志华,樊翌明.皮肤性病诊断与鉴别诊断[M]. 北京:科学技术文献出版社, 2018:784.
[2] 易子寒.实用肿瘤诊断与治疗决策[M].长春:吉林科学技术出版社,2019: 453
[3] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020 [J]. CA Cancer J Clin, 2020, 70(1): 7-30. DOI: 10.3322/caac.21590.
[4] 中国抗癌协会肉瘤专业委员会软组织肉瘤及恶性黑色素瘤学组. 皮肤和肢端恶性黑色素瘤的外科治疗规范中国专家共识1.0[J]. 中华肿瘤杂志,2020,42(2):81-93. DOI:10.3760/cma.j.issn.0253-3766.2020.02.001.
[5] Low CM, Price DL, Moore EJ, et al. Nodal and distant metastases in sinonasal mucosal melanoma: a population-based analysis [J]. Laryngoscope, 2020, 130(3): 622-627. DOI: 10.1002/lary.28065.
[6] Falk Delgado A, Zommorodi S, Falk Delgado A. Sentinel lymph node biopsy and complete lymph node dissection for melanoma [J]. Curr Oncol Rep, 2019, 21(6): 54. DOI: 10.1007/s11912-019-0798-y.
[7] Diener-West M, Reynolds SM, Agugliaro DJ, et al. Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26 [J]. Arch Ophthalmol, 2005, 123(12):1639-1643. DOI: 10.1001/archopht.123.12.1639.
[8] 倪军,张力. 肿瘤免疫治疗相关不良反应研究进展[J]. 中华内科杂志,2021,60(1):84-89. DOI:10.3760/cma.j.cn112138-20200308-00204.
[9] Lindsay CR, Spiliopoulou P, Waterston A. Blinded by the light: why the treatment of metastatic melanoma has created a new paradigm for the management of cancer [J]. Ther Adv Med Oncol, 2015, 7(2):107-121. DOI: 10.1177/1758834014566619.
[10] Kozar I, Margue C, Rothengatter S, et al. Many ways to resistance: how melanoma cells evade targeted therapies [J]. Biochim Biophys Acta Rev Cancer, 2019, 1871(2): 313-322. DOI: 10.1016/j.bbcan.2019.02.002.
[11] Bouchard J. Mechanism of action of 5-AZA-dC: induced DNA hypomethylation does not lead to aberrant gene expression in human leukemic CEM cells [J]. Leuk Res, 1989, 13(8): 715-722. DOI: 10.1016/0145-2126(89)90061-1.
[12] Jung Y, Park J, Kim TY, et al. Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy [J]. J Mol Med (Berl), 2007, 85(10): 1137-1148. DOI: 10.1007/s00109-007-0216-z.
[13] Murai M, Toyota M, Satoh A, et al. Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours [J]. Br J Cancer, 2005, 92(6): 1165-1172. DOI: 10.1038/sj.bjc.6602422.
[14] Lan L, Cao H, Chi W, et al. Aberrant DNA hypermethylation-silenced LINC00886 gene accelerates malignant progression of laryngeal carcinoma [J]. Pathol Res Pract, 2020, 216(4): 152877. DOI: 10.1016/j.prp.2020.152877.
[15] Jin X, Li Y, Guo Y, et al. ERα is required for suppressing OCT4-induced proliferation of breast cancer cells via DNMT1/ISL1/ERK axis [J]. Cell Prolif, 2019, 52(4): e12612. DOI: 10.1111/cpr.12612.
[16] Miao Z, Wu F, Wei H, et al. Enhancer of zeste homolog 2-mediated paired box 8 methylation promotes gastrointestinal stromal tumor progression through Wnt4 downregulation [J]. Cancer Gene Ther, 2021, 28(10-11): 1162-1174. DOI: 10.1038/s41417-020-00266-5.
[17] Lantry LE, Zhang Z, Crist KA, et al. 5-Aza-2'-deoxycytidine is chemopreventive in a 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone-induced primary mouse lung tumor model [J]. Carcinogenesis, 1999, 20(2): 343-346. DOI: 10.1093/carcin/20.2.343.
[18] Guy GP, Thomas CC, Thompson T, et al. Vital signs: melanoma incidence and mortality trends and projections - United States, 1982-2030 [J]. MMWR Morb Mortal Wkly Rep, 2015, 64(21): 591-596.
[19] Eitzman DT, Krauss JC, Shen T, et al. Lack of plasminogen activator inhibitor-1 effect in a transgenic mouse model of metastatic melanoma [J]. Blood, 1996, 87(11): 4718-4722.
[20] Syed HR, Shekar S, Aravantagi A. Melanoma and the gastrointestinal (GI) tract: maintaining a high index of suspicion [J]. Cureus, 2021, 13(2): e13408. DOI: 10.7759/cureus.13408.
[21] Li Y, Su X, Rohatgi N, et al. Hepatic lipids promote liver metastasis [J]. JCI Insight, 2020, 5(17): e136215. DOI: 10.1172/jci.insight.136215.
[22] Wang Y, Lian B, Si L, et al. Real-world analysis of clinicopathological characteristics, survival rates, and prognostic factors in patients with melanoma brain metastases in China [J]. J Cancer Res Clin Oncol, 2021, 147(9): 2731-2740. DOI: 10.1007/s00432-021-03563-0.
[23] Malmusi S, Airoud M, Bellafronte M, et al. Spontaneous subcapsular and perirenal haemorrhage with retroperitoneal haematoma in a patient with ovarian melanoma metastases [J]. BMJ Case Rep, 2021, 14(1): e238983. DOI: 10.1136/bcr-2020-238983.
[24] Reu FJ, Bae SI, Cherkassky L, et al. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation [J]. J Clin Oncol, 2006, 24(23):3771-3779. DOI: 10.1200/JCO.2005.03.4074.
[25] Reu FJ, Leaman DW, Maitra RR, et al. Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons [J]. Cancer Res, 2006, 66(5):2785-93. DOI: 10.1158/0008-5472.CAN-05-2303.
[26] Nobeyama Y, Okochi-Takada E, Furuta J, et al. Silencing of tissue factor pathway inhibitor-2 gene in malignant melanomas [J]. Int J Cancer, 2007, 121(2): 301-307. DOI: 10.1002/ijc.22637.
[27] Lindner DJ, Wu Y, Haney R, et al. Thrombospondin-1 expression in melanoma is blocked by methylation and targeted reversal by 5-Aza-deoxycytidine suppresses angiogenesis [J]. Matrix Biol, 2013, 32(2): 123-132. DOI: 10.1016/j.matbio.2012.11.010.
[28] Zhang YW, Staal B, Dykema KJ, et al. Cancer-type regulation of MIG-6 expression by inhibitors of methylation and histone deacetylation [J]. PLoS One, 2012, 7(6): e38955. DOI: 10.1371/journal.pone.0038955.
[29] 张彩霞,江滨,张亚杰,等. 间隙连接蛋白Cx43在肿瘤发生发展中作用[J]. 辽宁中医药大学学报,2017,19(1):147-151. DOI:10.13194/j.issn.1673-842x.2017.01.044.
[30] 王峻岭,李慧,张冀北,等. 皮肤恶性黑色素瘤患者Cx43表达水平及预后影响因素分析[J]. 安徽医学,2020,41(2):134-137. DOI:10.3969/j.issn.1000-0399.2020.02.005.
[31] 迟强,宋殿宾,王泽民,等. Cx43在膀胱移行细胞癌组织中的表达及其与Bcl-2、bax表达的关系[J]. 临床泌尿外科杂志,2020,35(1):41-43. DOI:10.13201/j.issn.1001-1420.2020.01.010.
[32] Glinsky GV, Glinsky VV. Apoptosis amd metastasis: a superior resistance of metastatic cancer cells to programmed cell death [J]. Cancer Lett, 1996, 101(1): 43-51. DOI: 10.1016/0304-3835(96)04112-2.
[33] Nicolson GL, Dulski K, Basson C, et al. Preferential organ attachment and invasion in vitro by B16 melanoma cells selected for differing metastatic colonization and invasive properties [J]. Invasion Metastasis, 1985, 5(3): 144-158.
|